CIK 0001599298
- Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 371979717
- Phone
- +1 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-16 | DUGGAN ROBERT W Co-Chief Executive Officer | Option exercise | +500,000 | $1.06 | $530K | 531,000 |
| 2026-11-16 | DUGGAN ROBERT W Co-Chief Executive Officer | Option exercise · Stock Option (right to buy) | −500,000 | 800,000 | ||
| 2026-06-12 | DUGGAN ROBERT W Co-Chief Executive Officer | Purchase | +3,810,000 | $13.12 | $50.0M | 573,883,879 |
| 2026-06-04 | DUGGAN ROBERT W Co-Chief Executive Officer | Purchase | +100,000 | $14.60 | $1.5M | 25,824,474 |
| 2026-01-02 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +11,232 | $8.76 | $98K | 11,232 |
| 2025-10-21 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award | +13,980,789 | $18.74 | $262.0M | 570,073,879 |
| 2025-10-21 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award | +266,808 | $18.74 | $5.0M | 25,724,474 |
| 2025-10-21 | DUGGAN ROBERT W Co-Chief Executive Officer | Purchase | +26,680 | $18.74 | $500K | 76,680 |
| 2025-09-11 | DUGGAN ROBERT W Co-Chief Executive Officer | Purchase | +5,000 | $18.07 | $90K | 556,093,090 |
| 2025-09-10 | DUGGAN ROBERT W Co-Chief Executive Officer | Purchase | +333,394 | $17.68 | $5.9M | 556,088,090 |
| 2025-05-30 | DUGGAN ROBERT W Co-Chief Executive Officer | Option exercise | +74,545 | $2.64 | $197K | 555,754,696 |
| 2025-05-30 | DUGGAN ROBERT W Co-Chief Executive Officer | Option exercise · Stock Option (right to buy) | −74,545 | 0 | ||
| 2025-04-29 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,040,000 | 1,040,000 | ||
| 2025-04-29 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2025-04-29 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +9,590,558 | 9,590,558 | ||
| 2025-04-08 | DUGGAN ROBERT W Co-Chief Executive Officer | Option exercise | +3,985,055 | $1.58 | $6.3M | 555,680,151 |
| 2025-04-08 | DUGGAN ROBERT W Co-Chief Executive Officer | Option exercise · Warrant (right to buy) | +3,985,055 | 0 | ||
| 2025-01-02 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +10,724 | $9.18 | $98K | 10,724 |
| 2024-09-11 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award | +3,325,991 | $22.70 | $75.5M | 551,695,096 |
| 2024-01-02 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +74,545 | $1.32 | $98K | 74,545 |
Page 1 of 2 · 27 trades